Patrick Stephen Gallagher - 01 Jun 2022 Form 3 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role: Chief Business Officer
Signature: /s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol: SNSE
Transactions as of: 01 Jun 2022
Net transactions value: $0
Form type: 3
Filing time: 03 Jun 2022, 16:15:58 UTC
Next filing: 29 Mar 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney